Abstract
Gut microbiota has been confirmed to be closely related to Alzheimer’s disease (AD). Research on gut microbiota and AD has also increased significantly. This study aimed to conduct a bibliometric and visual analysis of published studies related to gut microbiota and AD. Based on the Web of Science Core Collection SCI-Expanded database, we utilize Excel 2019 and visualization analysis tools VOSviewer, Co-Occurrence13.2 (COOC13.2), Citespace, HistCite, and Bibliometrix (R-Tool of R-Studio) for analysis. A total of 1093 related kinds of literature were included, and the number of papers presented an overall increasing trend. The country/region with the most publications is China, the institution is Zhejiang University, the author is Walter J Lukiw from the USA, and the journal is the Journal of Alzheimer’s Disease. Hotspot research areas include the relationship between gut microbiota metabolism and AD, AD treatments related to the gut microbiota, and diseases related to AD and gut microbiota. The future research direction may be T cells, NLRP3 inflammasome, and Porphyromonas gingivalis. Studies on AD and gut microbiota have grown rapidly in recent years. Our research results may provide valuable references for readers and help researchers better find new research directions in the future.
Similar content being viewed by others
Data Availability
No datasets were generated or analysed during the current study.
References
Kim N, Jeon SH, Ju IG, Gee MS, Do J, Oh MS, Lee JK (2021) Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice. Brain Behav Immun 98:357–365
Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, Ye S, Ye K, Wei D, Song Z et al (2019) Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice. Transl Psychiat 9(1):189
Kawase T, Nagasawa M, Ikeda H, Yasuo S, Koga Y, Furuse M (2017) Gut microbiota of mice putatively modifies amino acid metabolism in the host brain. Brit J Nutr 117(6):775–783
Nagpal R, Neth BJ, Wang S, Craft S, Yadav H (2019) Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer’s disease markers in subjects with mild cognitive impairment. EBioMedicine 47:529–542
Tatulian SA (2022) Challenges and hopes for Alzheimer’s disease. Drug Discov Today 27(4):1027–1043
Liu PP, Xie Y, Meng XY, Kang JS (2019) History and progress of hypotheses and clinical trials for Alzheimer’s disease. Signal Transduct Tar 4:29
Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68–80
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer’s disease. Lancet 397(10284):1577–1590
Cryan JF, O’Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179–194
Piccioni A, Cicchinelli S, Valletta F, De Luca G, Longhitano Y, Candelli M, Ojetti V, Sardeo F, Navarra S, Covino M et al (2022) Gut microbiota and autoimmune diseases: a charming real world together with probiotics. Curr Med Chem 29(18):3147–3159
Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM et al (2016) The gut microbiota and host health: a new clinical frontier. Gut 65(2):330–339
Doifode T, Giridharan VV, Generoso JS, Bhatti G, Collodel A, Schulz PE, Forlenza OV, Barichello T (2021) The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology. Pharmacol Res 164:105314
Zhu H, Zhang Y, Feng S, Li Y, Ye Y, Jian Z, Xiong X, Gu L (2023) Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: a bibliometric analysis. CNS Neurosci Ther 29(10):2940–2954
Zhang Y, Peng Y, Xia X (2023) Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022. Clin Exp Med 23(6):2813–2827
Chen C (2004) Searching for intellectual turning points progressive knowledge domain visualization. P Natl Acad Sci USA 101(Suppl 1): 5303–5310
Massimo Aria CC (2017) bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr 11(4):959–975
Zhang Y, Jia Z, Xia X, Wang J (2023) Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis. Clin Exp Med 23(7):3549–3564
Wang XW, Fang ZC, Sun XL (2016) Usage patterns of scholarly articles on Web of Science: a study on Web of Science usage count. Scientometrics 109(2):917–926
Cryan JF, O’Riordan KJ, Cowan C, Sandhu KV, Bastiaanssen T, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV et al (2019) The microbiota-gut-brain axis. Physiol Rev 99(4):1877–2013
Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, Xie Z, Chu X, Yang J, Wang H et al (2019) Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res 29(10):787–803
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano G, Gasbarrini A, Mele MC (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7(1):14
Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C et al (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60–68
Zhuang ZQ, Shen LL, Li WW, Fu X, Zeng F, Gui L, Lü Y, Cai M, Zhu C, Tan YL et al (2018) Gut microbiota is altered in patients with Alzheimer’s disease. J Alzheimers Dis 63(4):1337–1346
Jiang C, Li G, Huang P, Liu Z, Zhao B (2017) The gut microbiota and Alzheimer’s disease. J Alzheimers Dis 58(1):1–15
Colombo AV, Sadler RK, Llovera G, Singh V, Roth S, Heindl S, Sebastian ML, Verhoeven A, Peters F, Parhizkar S et al (2021) Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition. Elife 13(10):e59826
Tran T, Corsini S, Kellingray L, Hegarty C, Le Gall G, Narbad A, Müller M, Tejera N, O’Toole PW, Minihane AM et al (2019) APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer’s disease pathophysiology. FASEB J 33(7):8221–8231
Sun J, Zhang S, Zhang X, Zhang X, Dong H, Qian Y (2015) IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation. J Neuroinflamm 12:165
André P, Laugerette F, Féart C (2019) Metabolic endotoxemia: a potential underlying mechanism of the relationship between dietary fat intake and risk for cognitive impairments in humans? Nutrients 11(8):1887
Agostini A, Yuchun D, Li B, Kendall DA, Pardon MC (2020) Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer’s disease. Brain Behav Immun 83:87–111
Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S (2012) Host-gut microbiota metabolic interactions. Science 336(6086):1262–1267
MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW et al (2019) Altered bile acid profile associates with cognitive impairment in Alzheimer’s disease-an emerging role for gut microbiome. Alzheimers Dement 15(1):76–92
Huang F, Pariante CM, Borsini A (2022) From dried bear bile to molecular investigation: a systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders. Brain Behav Immun 99:132–146
Kwon YH, Wang H, Denou E, Ghia JE, Rossi L, Fontes ME, Bernier SP, Shajib MS, Banskota S, Collins SM et al (2019) Modulation of gut microbiota composition by serotonin signaling influences intestinal immune response and susceptibility to colitis. Cell Mol Gastroenter 7(4):709–728
De-Paula VDJR, Forlenza AS, Forlenza OV (2018) Relevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease. Pharmacol Res 136:29–34
Rawat K, Singh N, Kumari P, Saha L (2021) A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective. REV Neuroscience 32(2):143–157
Mangiola F, Nicoletti A, Gasbarrini A, Ponziani FR (2018) Gut microbiota and aging. Eur Rev Med Pharmaco 22(21):7404–7413
Correale J, Hohlfeld R, Baranzini SE (2022) The role of the gut microbiota in multiple sclerosis. Nat Rev Neurol 18(9):544–558
Stoiloudis P, Kesidou E, Bakirtzis C, Sintila SA, Konstantinidou N, Boziki M, Grigoriadis N (2022) The role of diet and interventions on multiple sclerosis: a review. Nutrients 14(6):1150
Pröbstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A et al (2020) Gut microbiota-specific IgA(+) B cells traffic to the CNS in active multiple sclerosis. Sci Immunol 5(53):eabc7191
Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S (2022) A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin Microbiol Rev 35(1):e0033820
Lavelle A, Sokol H (2020) Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastro Hepat 17(4):223–237
Zhang B, Wang HE, Bai YM, Tsai SJ, Su TP, Chen TJ, Wang YP, Chen MH (2021) Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut 70(1):85–91
Huang Y, Xu W, Zhou R (2021) NLRP3 inflammasome activation and cell death. Cell Mol Immunol 18(9):2114–2127
Milner MT, Maddugoda M, Götz J, Burgener SS, Schroder K (2021) The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer’s disease. Curr Opin Immunol 68:116–124
Ryder MI (2020) Porphyromonas gingivalis and Alzheimer disease: recent findings and potential therapies. J Periodontol 91(Suppl 1):S45–S49
Costa M, de Araújo I, Da RAL, Da SR, Dos SCP, Borges B, de Aquino MA, de Vasconcelos GB, Lins R (2021) Relationship of Porphyromonas gingivalis and Alzheimer’s disease: a systematic review of pre-clinical studies. Clin Oral Invest 25(3):797–806
Choi J, Kim BR, Akuzum B, Chang L, Lee JY, Kwon HK (2022) T(REG)king from gut to brain: the control of regulatory T cells along the gut-brain axis. FRONT Immunol 13:916066
Xiu R, Sun Q, Li B, Wang Y (2023) Mapping research trends and hotspots in the link between Alzheimer’s disease and gut microbes over the past decade: a bibliometric analysis. Nutrients 15(14):3203
Li ZL, Ma HT, Wang M, Qian YH (2022) Research trend of microbiota-gut-brain axis in Alzheimer’s disease based on CiteSpace (2012–2021): a bibliometrics analysis of 608 articles. Front Aging Neurosci 14:1036120
Trejo-Castro AI, Carrion-Alvarez D, Martinez-Torteya A, Rangel-Escareño C (2022) A bibliometric review on gut microbiome and Alzheimer’s disease between 2012 and 2021. Front Aging Neurosci 14:804177
Karri S, Acosta-Martinez V, Coimbatore G (2010) Effect of dihydrotestosterone on gastrointestinal tract of male Alzheimer’s disease transgenic mice. Indian J Exp Biol 48(5):453–465
Fan L, Mao C, Hu X, Zhang S, Yang Z, Hu Z, Sun H, Fan Y, Dong Y, Yang J et al (2019) New insights into the pathogenesis of Alzheimer’s disease. Front Neurol 10:1312
Sjogren T, Sjogren H, Lindgren AG (1952) Morbus Alzheimer and morbus Pick; a genetic, clinical and patho-anatomical study. Acta Psychiatr Neurol Scand Suppl 82:1–152
Funding
This work was supported by the Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province (grant number pdjh2023b0107) and National College Students Innovation and Entrepreneurship Training Program (grant number 202212121008), Medical Research Foundation of Guangdong Province (grant number A2022362), Shenzhen Science and Technology Planning Project (grant number JCYJ20220530165014033), Medical research project of Shenzhen Longhua Medical Association (2023LHMA10), the Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen (grant number 2021017), and Shenzhen Medical Key Discipline (grant number MKD202007090201).
Author information
Authors and Affiliations
Contributions
Y.Z. Conceptualization, Methodology, Investigation, Writing, Reviewing and Editing. Z.J. Drawing, Reviewing and Editing J.W. Methodology, Fund support, Reviewing and Editing. H.L. Fund support, Reviewing and Editing.
Corresponding authors
Ethics declarations
Ethical Approval
The data are all from the public database Web of Science, which does not involve ethical issues.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, Y., Jia, Z., Wang, J. et al. Research Hotspots and Frontiers of Alzheimer’s Disease and Gut Microbiota: A Knowledge Mapping and Text Mining Analysis. Mol Neurobiol (2024). https://doi.org/10.1007/s12035-024-04168-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12035-024-04168-7